Matt Parry

Health Data Research Service (HDRS) @HDR_UK Digital Ecosystem Analysis: Final report wellcomeopenresearch-files.f1000.com/posters/docs/w…

A Merry Dickensian Christmas from @urology_history - Charles Dickens suffered with ureteric colic for most of his life. He took hydrocyanic acid, laudanum and henbane for he spasm and pain and wore a broad flannel belt around his waist. pic @DickensMuseum

@gusviani @OncoAlert Did you look at toxicity? National English data showing GI toxicity worse with LDR boost: pubmed.ncbi.nlm.nih.gov/33279595/

HDR vs LDR Boost in Prostate Cancer: Is One Better? @OncoAlert New RCT sheds light on long-term efficacy for unfavorable-risk prostate cancer 🎯 Objective Compare HDR vs LDR brachytherapy boost + EBRT in terms of biochemical control 🏥 Methods •190 👥 randomized: HDR (15 Gy pre-EBRT) vs LDR (110 Gy post-EBRT) •All received pelvic EBRT (46 Gy/23 fx) via IMRT/VMAT or 3D-CRT •76% received ADT; median f/u 74 months •PSA ≤0.2 ng/ml at 4y = cure 📊 Key Results •4y PSA ≤0.2: HDR 81% | LDR 83% •8y bPFS: HDR 85% | LDR 84% •OS/CSS similar 🔛Takeway: Both techniques offer durable efficacy. Use may depend on center expertise &👥 factors🤝

@pash22 @acesridhar @LondonProstate1 @RealJesseLuke @ProstateUK @ellapickover @susan_bewley @MichaelBaum11 @SteveLaitner @paulpharoah @naserturabi @rwittmer3 @ebmgatineau @RolandGrad @imperialcollege @Azeem_Majeed @muirgray @emmerdale @KimmelCancerCtr @JAMANetwork @DanielLinMD Have the US finally caught up then ? nature.com/articles/s4139…

'Treatment rates of prostate cancer were higher in the US compared to England raising potential over-treatment concerns for low-risk disease (CPG1) in the US and under-treatment of clinically significant disease (CPG3-5) in England', via @mparry7 et al

We are excited to welcome Dr Alison Tree to the National Prostate Cancer Audit as the Clinical Lead for Oncology. Alison joins us from The Royal Marsden NHS Foundation Trust where she is a Consultant clinical oncologist. You can follow Alison on @alison_tree

The National Prostate Cancer Audit's investigation of the organisation & delivery of supportive services for patients with prostate cancer in the NHS in England and Wales is in @BMJ_Open. @JoannaDodkins @JanvanderMeule6 @AggarwalOnc @GUresearch_MCR bmjopen.bmj.com/content/13/11/…

Delighted to announce a clinical fellowship in radiorecurrent prostate cancer at UCL/UCLH with @susan_heavey @gland_ambition in @UCLDivofSurgery! PhD funding included & opportunity to develop some very exciting work! Suitable for urologists and oncologists ucl.ac.uk/work-at-ucl/se…

📢 Exciting times at NATCAN as we welcome our new Clinical Director, Dr Ajay Aggarwal. Take a look at the full announcement on our website 📢 #NATCAN bit.ly/45XuSH7 @AggarwalOnc @LSHTM @HQIP @NHSEngland

Delighted to have been appointed Clinical Director of the National Cancer Audits in England and Wales. I look forward to working with clinical, policy and patient communities to drive improvements in the quality and experience of cancer care across the nine cancers.

@michaelroweuk2 Hello Michael. Thank you very much! Really pleased you found it informative. This really is a data goldmine, the future!

💡 Collecting RCT data can be expensive and time-consuming. What if there's a more efficient way? Learn how routine hospital administrative data can revolutionise clinical trials bit.ly/3pTPq3z @mattsydes @Prof_Nick_James @OncoAlert @HattieMintz

Routine data 🤩

@sacosw @Liz_ORiordan @NHSEngland Gender disparity persists in the UK surgical workforce and there are significant differences between surgical specialties esp' Vascular Surgery, Cardiothoracic Surgery, Neurosurgery & Trauma and Orthopaedics. bmjopen.bmj.com/content/12/2/e… via @mparry7 et al

Any urology trainee with a sub-specialty interest in kidney cancer should definitely apply! Access to huge national datasets with opportunities for MD/PhD in surgical outcomes research. Data ready to be analysed with scope for big output (if the @NPCA_uk is anything to go by)!

Radical Tx of CPG1 (low risk) 38% in 🇺🇸 vs 14% in 🏴󠁧󠁢󠁥󠁮󠁧󠁿 - I don't think the problem is what you call it but where your managed😏 - Comparison of the treatment of men with prostate cancer between the US and England: an international population-bas… pubmed.ncbi.nlm.nih.gov/35001083/

📢📢📢 CALLING ONCOLOGY COLLEAGUES 👀 Clinical Fellowship Opportunities to support the National Kidney Cancer Audit More info: Kidney Cancer fellow: ow.ly/EKW050OFGeh NATCAN clinical fellows - ow.ly/5KKg50OFGef DEADLINE: 25 June @jonathananing @grantissimus

New Competition. RT and follow (if you haven't already) to win this 12 x 8 inch Canning Dock, #Liverpool at Dawn print. The draw will be on Sunday, 21st May 2023.

Great stuff. HES linkage to trial data. The possibilities are endless!